ID   PC-3/nKR
AC   CVCL_M060
SY   PC3/nKR
DR   cancercelllines; CVCL_M060
DR   KCLB; 60069
DR   PRIDE; PXD008184
DR   Wikidata; Q54938421
RX   PubMed=31404090;
CC   Population: Caucasian.
CC   Characteristics: Compared to the parent cell line, has an increased cell migration capability and a higher number of invaded cell. Established from nude mice that were implanted with the parent cell line without anti-NK treatment.
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Omics: Secretome proteome analysis.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
ST   Source(s): KCLB
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,11
ST   FGA: 24
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 16
//
RX   PubMed=31404090; DOI=10.1371/journal.pone.0220807;
RA   Jeon J.M., Kwon O.K., Na A.-Y., Sung E.J., Cho I.J., Kim M., Yea S.S.,
RA   Chun S.Y., Lee J.H., Ha Y.-S., Kwon T.G., Lee S.;
RT   "Secretome profiling of PC3/nKR cells, a novel highly migrating
RT   prostate cancer subline derived from PC3 cells.";
RL   PLoS ONE 14:E0220807-E0220807(2019).
//